Skip to search formSkip to main contentSkip to account menu

Associated Pulmonary Arterial Hypertension

Known as: APAH 
Pulmonary hypertension that results from another disorder (e.g., connective tissue disorder).
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Cysteine-rich protein 61 as a novel biomarker in systemic lupus erythematosus-associated pulmonary arterial hypertension.
OBJECTIVES This study aimed to evaluate the level of plasma Cysteine rich 61 (Cyr61) in systemic lupus erythematosus (SLE… 
2019
2019
Efficacy of immunosuppressants with bridge vasodilator therapy in severe lupus erythematosus‐associated pulmonary arterial hypertension
Optimal management of systemic lupus erythematosus (SLE)‐associated pulmonary arterial hypertension (PAH) remains unclear. Our… 
2017
2017
Replacing a phosphodiesterase-5 inhibitor with riociguat in patients with connective tissue disease-associated pulmonary arterial hypertension: a case series
Patients with pulmonary arterial hypertension associated with connective tissue disease (PAH-PAH-CTD) such as systemic sclerosis… 
2015
2015
Targeted therapy is required for management of pulmonary arterial hypertension after defect closure in adult patients with atrial septal defect and associated pulmonary arterial hypertension.
BACKGROUND Therapeutic strategies for pulmonary arterial hypertension (PAH) associated with atrial septal defect (ASD) remain a… 
2015
2015
Effect of Th 17 and Treg Axis Disorder on Outcomes of Pulmonary Arterial Hypertension in Connective Tissue Diseases
This prospective cohort study is to verify the hypothesis that the balance of Th17 and Treg cells frequencies in the peripheral… 
2012
2012
Injection drug use as a "second hit" in the pathogenesis of HIV-associated pulmonary hypertension.
HIV-associated pulmonary arterial hypertension (HIV-PAH) is a serious complication that develops in approximately 1:200 of HIV… 
Review
2011
Review
2011
Drugs and toxins‐associated pulmonary arterial hypertension: lessons learned and challenges ahead
Since the identification of the link between pulmonary arterial hypertension (PAH) and exposure to certain drugs and toxins… 
Review
2011
Review
2011
Transforming growth factor signalling: a common pathway in pulmonary arterial hypertension and systemic sclerosis
Pulmonary arterial hypertension (PAH) is a clinical condition characterised by the presence of precapillary pulmonary… 
Review
2009
Review
2009
Genetics of systemic sclerosis-associated pulmonary arterial hypertension: Recent progress and current concepts
Pulmonary arterial hypertension (PAH) is a devastating complication of systemic sclerosis (SSc). Although there are screening… 
2008
2008
Lack of correlation of the health assessment questionnaire disability index with lung parameters in systemic sclerosis associated pulmonary arterial hypertension.
OBJECTIVE Pulmonary arterial hypertension (PAH) affects the quality of life (QoL) and the ability to perform the activities of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)